한글목차

부갑상선기능항진증 시장, 2024-2028년

부갑상선기능항진증 시장은 2023-2028년에 4억 8,670만 달러, 예측 기간 중 CAGR은 7.1%로 성장할 것으로 예측됩니다. 부갑상선기능항진증 시장의 전체적인 분석, 시장 규모·예측, 동향, 성장 촉진요인, 과제, 약 25개 벤더를 다룬 벤더 분석 등을 게재하고 있습니다.

현재 시장 시나리오, 최신 동향과 촉진요인, 시장 환경 전체에 관한 최신 분석을 제공하고 있습니다. 갑상선 치료 계발 프로그램의 증가, 신흥 국가에 대한 주목의 증가, Drug Discovery의 증가 등이 시장을 촉진하고 있습니다.

본 조사에서는 향후 수년간 부갑상선기능항진증 시장 성장을 촉진하는 주요 요인의 하나로 벤더간 무기적 성장 전략의 증가를 들고 있습니다. 또한 의약품 소매를 위한 E-Commerce의 침투 및 부갑상선기능항진증 치료의 임상시험 증가는 시장의 큰 수요로 연결됩니다.

목차

제1장 개요

• 시장 개요

제2장 Technavio 분석

• 가격·수명주기·고객 구입 바스켓·채택률·구입 기준 분석
• 인풋의 중요성과 차별화의 요인
• 혼란의 요인
• 촉진요인과 과제의 영향

제3장 시장 구도

• 시장 에코시스템
• 시장의 특징
• 밸류체인 분석

제4장 시장 규모의 평가

• 시장의 정의
• 시장 부문 분석
• 시장 규모 2023년
• 시장의 전망 2023-2028년

제5장 시장 규모 실적

• 세계의 부갑상선기능항진증 시장 2018-2022년
• 질환 유형별 부문 분석 2018-2022년
• 유통 채널별 부문 분석 2018-2022년
• 지역별 부문 분석 2018-2022년
• 국가별 부문 분석 2018-2022년

제6장 정성 분석

• 세계의 부갑상선기능항진증 시장에 대한 AI의 영향

제7장 Five Forces 분석

• Five Forces 요약
• 바이어의 교섭력
• 공급 기업의 교섭력
• 신규 진출업체의 위협
• 대체품의 위협
• 경쟁의 위협
• 시장 현황

제8장 시장 세분화 : 질환 유형별

• 시장 세분화
• 비교 : 질환 유형별
• 2차 부갑상선기능항진증 : 시장 규모와 예측 2023-2028년
• 1차 부갑상선기능항진증 : 시장 규모와 예측 2023-2028년
• 3차 부갑상선기능항진증 : 시장 규모와 예측 2023-2028년
• 질병 유형별 시장 기회

제9장 시장 세분화 : 유통 채널별

• 시장 세분화
• 비교 : 유통 채널별
• 병원 약국 : 시장 규모와 예측 2023-2028년
• 소매 약국 : 시장 규모와 예측 2023-2028년
• 온라인 약국 : 시장 규모와 예측 2023-2028년
• 유통 채널별 시장 기회

제10장 고객 상황

• 고객 상황 개요

제11장 지역별 상황

• 지역별 세분화
• 비교 : 지역별
• 북미 : 시장 규모와 예측 2023-2028년
• 유럽 : 시장 규모와 예측 2023-2028년
• 아시아 : 시장 규모와 예측 2023-2028년
• 기타 : 시장 규모와 예측 2023-2028년
• 미국 : 시장 규모와 예측 2023-2028년
• 중국 : 시장 규모와 예측 2023-2028년
• 독일 : 시장 규모와 예측 2023-2028년
• 영국 : 시장 규모와 예측 2023-2028년
• 프랑스 : 시장 규모와 예측 2023-2028년
• 인도 : 시장 규모와 예측 2023-2028년
• 일본 : 시장 규모와 예측 2023-2028년
• 브라질 : 시장 규모와 예측 2023-2028년
• 이탈리아 : 시장 규모와 예측 2023-2028년
• 한국 : 시장 규모와 예측 2023-2028년
• 지역 상황별 시장 기회

제12장 촉진요인·과제·기회·억제요인

• 시장 성장 촉진요인
• 시장이 해결해야 할 과제
• 촉진요인과 과제의 영향
• 시장의 기회·억제요인

제13장 경쟁 구도

• 개요
• 경쟁 구도
• 혼란 상황
• 업계의 리스크

제14장 경쟁 분석

• 기업 개요
• 기업 순위 지수
• 기업의 시장 포지셔닝
• AbbVie Inc.
• Alkem Laboratories Ltd.
• Amgen Inc.
• Aurobindo Pharma Ltd.
• Biocon Ltd.
• Cipla Inc.
• Dr Reddys Laboratories Ltd.
• F. Hoffmann La Roche Ltd.
• Fresenius SE and Co. KGaA
• Lupin Ltd.
• Sanofi SA
• Sun Pharmaceutical Industries Ltd.
• Teva Pharmaceutical Industries Ltd.
• Viatris Inc.
• Zydus Lifesciences Ltd.

제15장 부록

영문목차

Hyperparathyroidism Market 2024-2028

The hyperparathyroidism market is forecasted to grow by USD 486.7 mn during 2023-2028, accelerating at a CAGR of 7.1% during the forecast period. The report on the hyperparathyroidism market provides a holistic analysis, market size and forecast, trends, growth drivers, and challenges, as well as vendor analysis covering around 25 vendors.

The report offers an up-to-date analysis regarding the current market scenario, the latest trends and drivers, and the overall market environment. The market is driven by rise in thyroid treatment awareness programs, growing focus on emerging economies, and increasing drug discovery.

Technavio's hyperparathyroidism market is segmented as below:

By Disease Type

• Secondary hyperparathyroidism
• Primary hyperparathyroidism
• Tertiary hyperparathyroidism

By Distribution Channel

• Hospital pharmacy
• Retail pharmacy
• Online pharmacy

By Geographical Landscape

• North America
• Europe
• Asia
• Rest of World (ROW)

This study identifies the increasing inorganic growth strategies among vendors as one of the prime reasons driving the hyperparathyroidism market growth during the next few years. Also, growing penetration of e-commerce for drug retail and rising clinical trials for hyperparathyroidism treatment will lead to sizable demand in the market.

The report on the hyperparathyroidism market covers the following areas:

• Hyperparathyroidism Market sizing
• Hyperparathyroidism Market forecast
• Hyperparathyroidism Market industry analysis

The robust vendor analysis is designed to help clients improve their market position, and in line with this, this report provides a detailed analysis of several leading hyperparathyroidism market vendors that include AbbVie Inc., Accord Healthcare Ltd., AdvaCare Pharma, Alkem Laboratories Ltd., Amgen Inc., Ascendis Pharma AS, Aurobindo Pharma Ltd., Biocon Ltd., Cipla Inc., Dr Reddys Laboratories Ltd., EA Pharma Co. Ltd., F. Hoffmann La Roche Ltd., Fresenius SE and Co. KGaA, Lupin Ltd., Sanofi SA, Sun Pharmaceutical Industries Ltd., Teva Pharmaceutical Industries Ltd., Viatris Inc., and Zydus Lifesciences Ltd.. Also, the hyperparathyroidism market analysis report includes information on upcoming trends and challenges that will influence market growth. This is to help companies strategize and leverage all forthcoming growth opportunities.

The study was conducted using an objective combination of primary and secondary information including inputs from key participants in the industry. The report contains a comprehensive market and vendor landscape in addition to an analysis of the key vendors.

The publisher presents a detailed picture of the market by the way of study, synthesis, and summation of data from multiple sources by an analysis of key parameters such as profit, pricing, competition, and promotions. It presents various market facets by identifying the key industry influencers. The data presented is comprehensive, reliable, and a result of extensive primary and secondary research. The market research reports provide a complete competitive landscape and an in-depth vendor selection methodology and analysis using qualitative and quantitative research to forecast accurate market growth.

Table of Contents

1 Executive Summary

• 1.1 Market overview
  • Executive Summary - Chart on Market Overview
  • Executive Summary - Data Table on Market Overview
  • Executive Summary - Chart on Global Market Characteristics
  • Executive Summary - Chart on Market By Geographical Landscape
  • Executive Summary - Chart on Market Segmentation by Disease Type
  • Executive Summary - Chart on Market Segmentation by Distribution Channel
  • Executive Summary - Chart on Incremental Growth
  • Executive Summary - Data Table on Incremental Growth
  • Executive Summary - Chart on Company Market Positioning

2 Technavio Analysis

• 2.1 Analysis of price sensitivity, lifecycle, customer purchase basket, adoption rates, and purchase criteria
  • Analysis of price sensitivity, lifecycle, customer purchase basket, adoption rates, and purchase criteria
• 2.2 Criticality of inputs and Factors of differentiation
  • Overview on criticality of inputs and factors of differentiation
• 2.3 Factors of disruption
  • Overview on factors of disruption
• 2.4 Impact of drivers and challenges
  • Impact of drivers and challenges in 2023 and 2028

3 Market Landscape

• 3.1 Market ecosystem
  • Parent Market
  • Data Table on - Parent Market
• 3.2 Market characteristics
  • Market characteristics analysis
• 3.3 Value chain analysis
  • Value Chain Analysis

4 Market Sizing

• 4.1 Market definition
  • Offerings of companies included in the market definition
• 4.2 Market segment analysis
  • Market segments
• 4.3 Market size 2023
• 4.4 Market outlook: Forecast for 2023-2028
  • Chart on Global - Market size and forecast 2023-2028 ($ million)
  • Data Table on Global - Market size and forecast 2023-2028 ($ million)
  • Chart on Global Market: Year-over-year growth 2023-2028 (%)
  • Data Table on Global Market: Year-over-year growth 2023-2028 (%)

5 Historic Market Size

• 5.1 Global Hyperparathyroidism Market 2018 - 2022
  • Historic Market Size - Data Table on Global Hyperparathyroidism Market 2018 - 2022 ($ million)
• 5.2 Disease Type segment analysis 2018 - 2022
  • Historic Market Size - Disease Type Segment 2018 - 2022 ($ million)
• 5.3 Distribution Channel segment analysis 2018 - 2022
  • Historic Market Size - Distribution Channel Segment 2018 - 2022 ($ million)
• 5.4 Geography segment analysis 2018 - 2022
  • Historic Market Size - Geography Segment 2018 - 2022 ($ million)
• 5.5 Country segment analysis 2018 - 2022
  • Historic Market Size - Country Segment 2018 - 2022 ($ million)

6 Qualitative Analysis

• 6.1 The Impact of AI on Global Hyperparathyroidism Market

7 Five Forces Analysis

• 7.1 Five forces summary
  • Five forces analysis - Comparison between 2023 and 2028
• 7.2 Bargaining power of buyers
  • Bargaining power of buyers - Impact of key factors 2023 and 2028
• 7.3 Bargaining power of suppliers
  • Bargaining power of suppliers - Impact of key factors in 2023 and 2028
• 7.4 Threat of new entrants
  • Threat of new entrants - Impact of key factors in 2023 and 2028
• 7.5 Threat of substitutes
  • Threat of substitutes - Impact of key factors in 2023 and 2028
• 7.6 Threat of rivalry
  • Threat of rivalry - Impact of key factors in 2023 and 2028
• 7.7 Market condition
  • Chart on Market condition - Five forces 2023 and 2028

8 Market Segmentation by Disease Type

• 8.1 Market segments
  • Chart on Disease Type - Market share 2023-2028 (%)
  • Data Table on Disease Type - Market share 2023-2028 (%)
• 8.2 Comparison by Disease Type
  • Chart on Comparison by Disease Type
  • Data Table on Comparison by Disease Type
• 8.3 Secondary hyperparathyroidism - Market size and forecast 2023-2028
  • Chart on Secondary hyperparathyroidism - Market size and forecast 2023-2028 ($ million)
  • Data Table on Secondary hyperparathyroidism - Market size and forecast 2023-2028 ($ million)
  • Chart on Secondary hyperparathyroidism - Year-over-year growth 2023-2028 (%)
  • Data Table on Secondary hyperparathyroidism - Year-over-year growth 2023-2028 (%)
• 8.4 Primary hyperparathyroidism - Market size and forecast 2023-2028
  • Chart on Primary hyperparathyroidism - Market size and forecast 2023-2028 ($ million)
  • Data Table on Primary hyperparathyroidism - Market size and forecast 2023-2028 ($ million)
  • Chart on Primary hyperparathyroidism - Year-over-year growth 2023-2028 (%)
  • Data Table on Primary hyperparathyroidism - Year-over-year growth 2023-2028 (%)
• 8.5 Tertiary hyperparathyroidism - Market size and forecast 2023-2028
  • Chart on Tertiary hyperparathyroidism - Market size and forecast 2023-2028 ($ million)
  • Data Table on Tertiary hyperparathyroidism - Market size and forecast 2023-2028 ($ million)
  • Chart on Tertiary hyperparathyroidism - Year-over-year growth 2023-2028 (%)
  • Data Table on Tertiary hyperparathyroidism - Year-over-year growth 2023-2028 (%)
• 8.6 Market opportunity by Disease Type
  • Market opportunity by Disease Type ($ million)
  • Data Table on Market opportunity by Disease Type ($ million)

9 Market Segmentation by Distribution Channel

• 9.1 Market segments
  • Chart on Distribution Channel - Market share 2023-2028 (%)
  • Data Table on Distribution Channel - Market share 2023-2028 (%)
• 9.2 Comparison by Distribution Channel
  • Chart on Comparison by Distribution Channel
  • Data Table on Comparison by Distribution Channel
• 9.3 Hospital pharmacy - Market size and forecast 2023-2028
  • Chart on Hospital pharmacy - Market size and forecast 2023-2028 ($ million)
  • Data Table on Hospital pharmacy - Market size and forecast 2023-2028 ($ million)
  • Chart on Hospital pharmacy - Year-over-year growth 2023-2028 (%)
  • Data Table on Hospital pharmacy - Year-over-year growth 2023-2028 (%)
• 9.4 Retail pharmacy - Market size and forecast 2023-2028
  • Chart on Retail pharmacy - Market size and forecast 2023-2028 ($ million)
  • Data Table on Retail pharmacy - Market size and forecast 2023-2028 ($ million)
  • Chart on Retail pharmacy - Year-over-year growth 2023-2028 (%)
  • Data Table on Retail pharmacy - Year-over-year growth 2023-2028 (%)
• 9.5 Online pharmacy - Market size and forecast 2023-2028
  • Chart on Online pharmacy - Market size and forecast 2023-2028 ($ million)
  • Data Table on Online pharmacy - Market size and forecast 2023-2028 ($ million)
  • Chart on Online pharmacy - Year-over-year growth 2023-2028 (%)
  • Data Table on Online pharmacy - Year-over-year growth 2023-2028 (%)
• 9.6 Market opportunity by Distribution Channel
  • Market opportunity by Distribution Channel ($ million)
  • Data Table on Market opportunity by Distribution Channel ($ million)

10 Customer Landscape

• 10.1 Customer landscape overview
  • Analysis of price sensitivity, lifecycle, customer purchase basket, adoption rates, and purchase criteria

11 Geographic Landscape

• 11.1 Geographic segmentation
  • Chart on Market share By Geographical Landscape 2023-2028 (%)
  • Data Table on Market share By Geographical Landscape 2023-2028 (%)
• 11.2 Geographic comparison
  • Chart on Geographic comparison
  • Data Table on Geographic comparison
• 11.3 North America - Market size and forecast 2023-2028
  • Chart on North America - Market size and forecast 2023-2028 ($ million)
  • Data Table on North America - Market size and forecast 2023-2028 ($ million)
  • Chart on North America - Year-over-year growth 2023-2028 (%)
  • Data Table on North America - Year-over-year growth 2023-2028 (%)
• 11.4 Europe - Market size and forecast 2023-2028
  • Chart on Europe - Market size and forecast 2023-2028 ($ million)
  • Data Table on Europe - Market size and forecast 2023-2028 ($ million)
  • Chart on Europe - Year-over-year growth 2023-2028 (%)
  • Data Table on Europe - Year-over-year growth 2023-2028 (%)
• 11.5 Asia - Market size and forecast 2023-2028
  • Chart on Asia - Market size and forecast 2023-2028 ($ million)
  • Data Table on Asia - Market size and forecast 2023-2028 ($ million)
  • Chart on Asia - Year-over-year growth 2023-2028 (%)
  • Data Table on Asia - Year-over-year growth 2023-2028 (%)
• 11.6 Rest of World (ROW) - Market size and forecast 2023-2028
  • Chart on Rest of World (ROW) - Market size and forecast 2023-2028 ($ million)
  • Data Table on Rest of World (ROW) - Market size and forecast 2023-2028 ($ million)
  • Chart on Rest of World (ROW) - Year-over-year growth 2023-2028 (%)
  • Data Table on Rest of World (ROW) - Year-over-year growth 2023-2028 (%)
• 11.7 US - Market size and forecast 2023-2028
  • Chart on US - Market size and forecast 2023-2028 ($ million)
  • Data Table on US - Market size and forecast 2023-2028 ($ million)
  • Chart on US - Year-over-year growth 2023-2028 (%)
  • Data Table on US - Year-over-year growth 2023-2028 (%)
• 11.8 China - Market size and forecast 2023-2028
  • Chart on China - Market size and forecast 2023-2028 ($ million)
  • Data Table on China - Market size and forecast 2023-2028 ($ million)
  • Chart on China - Year-over-year growth 2023-2028 (%)
  • Data Table on China - Year-over-year growth 2023-2028 (%)
• 11.9 Germany - Market size and forecast 2023-2028
  • Chart on Germany - Market size and forecast 2023-2028 ($ million)
  • Data Table on Germany - Market size and forecast 2023-2028 ($ million)
  • Chart on Germany - Year-over-year growth 2023-2028 (%)
  • Data Table on Germany - Year-over-year growth 2023-2028 (%)
• 11.10 UK - Market size and forecast 2023-2028
  • Chart on UK - Market size and forecast 2023-2028 ($ million)
  • Data Table on UK - Market size and forecast 2023-2028 ($ million)
  • Chart on UK - Year-over-year growth 2023-2028 (%)
  • Data Table on UK - Year-over-year growth 2023-2028 (%)
• 11.11 France - Market size and forecast 2023-2028
  • Chart on France - Market size and forecast 2023-2028 ($ million)
  • Data Table on France - Market size and forecast 2023-2028 ($ million)
  • Chart on France - Year-over-year growth 2023-2028 (%)
  • Data Table on France - Year-over-year growth 2023-2028 (%)
• 11.12 India - Market size and forecast 2023-2028
  • Chart on India - Market size and forecast 2023-2028 ($ million)
  • Data Table on India - Market size and forecast 2023-2028 ($ million)
  • Chart on India - Year-over-year growth 2023-2028 (%)
  • Data Table on India - Year-over-year growth 2023-2028 (%)
• 11.13 Japan - Market size and forecast 2023-2028
  • Chart on Japan - Market size and forecast 2023-2028 ($ million)
  • Data Table on Japan - Market size and forecast 2023-2028 ($ million)
  • Chart on Japan - Year-over-year growth 2023-2028 (%)
  • Data Table on Japan - Year-over-year growth 2023-2028 (%)
• 11.14 Brazil - Market size and forecast 2023-2028
  • Chart on Brazil - Market size and forecast 2023-2028 ($ million)
  • Data Table on Brazil - Market size and forecast 2023-2028 ($ million)
  • Chart on Brazil - Year-over-year growth 2023-2028 (%)
  • Data Table on Brazil - Year-over-year growth 2023-2028 (%)
• 11.15 Italy - Market size and forecast 2023-2028
  • Chart on Italy - Market size and forecast 2023-2028 ($ million)
  • Data Table on Italy - Market size and forecast 2023-2028 ($ million)
  • Chart on Italy - Year-over-year growth 2023-2028 (%)
  • Data Table on Italy - Year-over-year growth 2023-2028 (%)
• 11.16 South Korea - Market size and forecast 2023-2028
  • Chart on South Korea - Market size and forecast 2023-2028 ($ million)
  • Data Table on South Korea - Market size and forecast 2023-2028 ($ million)
  • Chart on South Korea - Year-over-year growth 2023-2028 (%)
  • Data Table on South Korea - Year-over-year growth 2023-2028 (%)
• 11.17 Market opportunity By Geographical Landscape
  • Market opportunity By Geographical Landscape ($ million)
  • Data Tables on Market opportunity By Geographical Landscape ($ million)

12 Drivers, Challenges, and Opportunity/Restraints

• 12.1 Market drivers
• 12.2 Market challenges
• 12.3 Impact of drivers and challenges
  • Impact of drivers and challenges in 2023 and 2028
• 12.4 Market opportunities/restraints

13 Competitive Landscape

• 13.1 Overview
• 13.2 Competitive Landscape
  • Overview on criticality of inputs and factors of differentiation
• 13.3 Landscape disruption
  • Overview on factors of disruption
• 13.4 Industry risks
  • Impact of key risks on business

14 Competitive Analysis

• 14.1 Companies profiled
  • Companies covered
• 14.2 Company ranking index
  • Company ranking index
• 14.3 Market positioning of companies
  • Matrix on companies position and classification
• 14.4 AbbVie Inc.
  • AbbVie Inc. - Overview
  • AbbVie Inc. - Product / Service
  • AbbVie Inc. - Key news
  • AbbVie Inc. - Key offerings
  • SWOT
• 14.5 Alkem Laboratories Ltd.
  • Alkem Laboratories Ltd. - Overview
  • Alkem Laboratories Ltd. - Business segments
  • Alkem Laboratories Ltd. - Key offerings
  • Alkem Laboratories Ltd. - Segment focus
  • SWOT
• 14.6 Amgen Inc.
  • Amgen Inc. - Overview
  • Amgen Inc. - Product / Service
  • Amgen Inc. - Key news
  • Amgen Inc. - Key offerings
  • SWOT
• 14.7 Aurobindo Pharma Ltd.
  • Aurobindo Pharma Ltd. - Overview
  • Aurobindo Pharma Ltd. - Product / Service
  • Aurobindo Pharma Ltd. - Key offerings
  • SWOT
• 14.8 Biocon Ltd.
  • Biocon Ltd. - Overview
  • Biocon Ltd. - Business segments
  • Biocon Ltd. - Key offerings
  • Biocon Ltd. - Segment focus
  • SWOT
• 14.9 Cipla Inc.
  • Cipla Inc. - Overview
  • Cipla Inc. - Business segments
  • Cipla Inc. - Key news
  • Cipla Inc. - Key offerings
  • Cipla Inc. - Segment focus
  • SWOT
• 14.10 Dr Reddys Laboratories Ltd.
  • Dr Reddys Laboratories Ltd. - Overview
  • Dr Reddys Laboratories Ltd. - Business segments
  • Dr Reddys Laboratories Ltd. - Key news
  • Dr Reddys Laboratories Ltd. - Key offerings
  • Dr Reddys Laboratories Ltd. - Segment focus
  • SWOT
• 14.11 F. Hoffmann La Roche Ltd.
  • F. Hoffmann La Roche Ltd. - Overview
  • F. Hoffmann La Roche Ltd. - Business segments
  • F. Hoffmann La Roche Ltd. - Key news
  • F. Hoffmann La Roche Ltd. - Key offerings
  • F. Hoffmann La Roche Ltd. - Segment focus
  • SWOT
• 14.12 Fresenius SE and Co. KGaA
  • Fresenius SE and Co. KGaA - Overview
  • Fresenius SE and Co. KGaA - Business segments
  • Fresenius SE and Co. KGaA - Key news
  • Fresenius SE and Co. KGaA - Key offerings
  • Fresenius SE and Co. KGaA - Segment focus
  • SWOT
• 14.13 Lupin Ltd.
  • Lupin Ltd. - Overview
  • Lupin Ltd. - Business segments
  • Lupin Ltd. - Key news
  • Lupin Ltd. - Key offerings
  • Lupin Ltd. - Segment focus
  • SWOT
• 14.14 Sanofi SA
  • Sanofi SA - Overview
  • Sanofi SA - Business segments
  • Sanofi SA - Key news
  • Sanofi SA - Key offerings
  • Sanofi SA - Segment focus
  • SWOT
• 14.15 Sun Pharmaceutical Industries Ltd.
  • Sun Pharmaceutical Industries Ltd. - Overview
  • Sun Pharmaceutical Industries Ltd. - Product / Service
  • Sun Pharmaceutical Industries Ltd. - Key news
  • Sun Pharmaceutical Industries Ltd. - Key offerings
  • SWOT
• 14.16 Teva Pharmaceutical Industries Ltd.
  • Teva Pharmaceutical Industries Ltd. - Overview
  • Teva Pharmaceutical Industries Ltd. - Business segments
  • Teva Pharmaceutical Industries Ltd. - Key news
  • Teva Pharmaceutical Industries Ltd. - Key offerings
  • Teva Pharmaceutical Industries Ltd. - Segment focus
  • SWOT
• 14.17 Viatris Inc.
  • Viatris Inc. - Overview
  • Viatris Inc. - Business segments
  • Viatris Inc. - Key news
  • Viatris Inc. - Key offerings
  • Viatris Inc. - Segment focus
  • SWOT
• 14.18 Zydus Lifesciences Ltd.
  • Zydus Lifesciences Ltd. - Overview
  • Zydus Lifesciences Ltd. - Business segments
  • Zydus Lifesciences Ltd. - Key news
  • Zydus Lifesciences Ltd. - Key offerings
  • Zydus Lifesciences Ltd. - Segment focus
  • SWOT

15 Appendix

• 15.1 Scope of the report
• 15.2 Inclusions and exclusions checklist
  • Inclusions checklist
  • Exclusions checklist
• 15.3 Currency conversion rates for US$
  • Currency conversion rates for US$
• 15.4 Research methodology
  • Research methodology
• 15.5 Data procurement
  • Information sources
• 15.6 Data validation
  • Data validation
• 15.7 Validation techniques employed for market sizing
  • Validation techniques employed for market sizing
• 15.8 Data synthesis
  • Data synthesis
• 15.9 360 degree market analysis
  • 360 degree market analysis
• 15.10 List of abbreviations
  • List of abbreviations